Business
2017 Annual Report and AGM Notice
2017 Annual Report and AGM Notice.
About this update from Genedrive Plc
[{"type":"text","content":"\n \nRNS Number : 8385W Genedrive PLC 17 November 2017 \n\nFor release: 17 November 2017\n \n \n2017 Annual Report and AGM Notice\ngenedrive plc (LSE: GDR), the near patient molecular diagnostics company, gives notice that copies of its 2017 Annual Report and Notice of the 2017 Annual General Meeting have been posted to shareholders. The AGM will be held at 12:00 on 29 November 2017 at the Company's premises at The Innovation Centre, 48 Grafton Street, Manchester M13 9XX.\nCopies of these documents may be found on the Company's website (www.genedriveplc.com)\n \n- Ends -\n \nFor further details please contact:\n\n\n\n\ngenedrive plc\n\n\n+44 (0)161 989 0245\n\n\n\n\nDavid Budd: CEO\n\n\n\n\n\n\n\nMatthew Fowler: CFO\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPeel Hunt LLP\n\n\n\n\n\n\n\nJames Steel\n\n\n+44 (0)207 418 8900\n\n\n\n\nOliver Jackson\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nConsilium Strategic Communications\n\n\n+44 (0)203 709 5700\n\n\n\n\nChris Gardner\n\n\n\n\n\n\n\nMatthew Neal\n\n\n\n\n\n\n\nLaura Thornton\n\n\n\n\n\n\n\[email protected]\n\n\n\n\n\n\n\n \nNotes to Editors\nAbout genedrive plc\ngenedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® platform and MTB/RIF test have been launched in India and a Genedrive® HCV test has received CE-IVD Certification.\nFurther details can be found at: www.genedriveplc.com and www.genedrive.com \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END NOABBBDBXDBBGRR\n ","length":5071,"tagName":"div"}]